I have Boston Medical as a treatment facility and Mayo Clinic has had two of my tissue samples but can't determine the type. Are there many different proteins out there that are still unidentified?
June 15
What are the main challenges and barriers to care for patients with undiagnosed or untyped amyloidosis?
Getting a confirmed amyloidosis diagnosis — and identifying the specific type — can be a long and frustrating road. On average, it takes about four years worldwide to reach a diagnosis. Because the misfolded proteins Show Full Answer
What are the main challenges and barriers to care for patients with undiagnosed or untyped amyloidosis?
Getting a confirmed amyloidosis diagnosis — and identifying the specific type — can be a long and frustrating road. On average, it takes about four years worldwide to reach a diagnosis. Because the misfolded proteins can't be seen from the outside, it can feel like an invisible illness that others don't take seriously. Here are some of the key barriers people face:
- Delayed diagnosis — Symptoms can mimic many other conditions, making it hard for doctors to identify amyloidosis early
- Misdiagnosis — Many patients are misdiagnosed, sometimes for years, before getting the correct answer
- Lack of awareness — Even among healthcare providers, awareness of amyloidosis remains low
- Identifying the type — Without knowing the specific type, treatment can't be properly targeted
- Organ involvement — Doctors may need to assess which organs are affected before a treatment plan can begin
- Specialist access — Not everyone has easy access to an amyloidosis specialist, which can slow down proper care
As one MyAmyloidosisTeam member put it, "Too many patients are misdiagnosed too late." If navigating an unconfirmed or untyped diagnosis, pushing for a referral to an amyloidosis specialist can make a real difference. They are best equipped to run the right tests, identify the type, and build a care plan tailored to specific needs.
June 15
Join
Your Privacy Choices
